Bloomage BioTechnology Corporation Limited (SHA:688363)

Market Cap	24.76B
Revenue (ttm)	4.66B
Net Income (ttm)	64.62M
Shares Out	478.36M
EPS (ttm)	0.13
PE Ratio	383.22
Forward PE	46.09
Dividend	0.11 (0.21%)
Ex-Dividend Date	Jul 14, 2025

Volume	1,625,570
Average Volume	2,573,300
Open	51.70
Previous Close	51.77
Day's Range	51.49 - 52.17
52-Week Range	42.51 - 65.00
Beta	0.71
RSI	43.34
Earnings Date	Oct 29, 2025

About SHA:688363

Bloomage BioTechnology Corporation Limited researchers, develops, produces, and sells bioactive materials. It offers pharmaceutical grade sodium hyaluronate which can be used as an API or excipient for drugs and medical devices in ophthalmic preparations, intra-articular injections, anti-adhesive preparations, and topical preparations for wound healing and soft tissue filler under the Hyature name; and cosmetic grade sodium hyaluronate solutions for cosmetic products, including moisturizing, repairing, delay skin aging, and brightening under th...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 2000
• Employees: 4,444
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688363

Financial Performance

In 2024, SHA:688363's revenue was 5.37 billion, a decrease of -11.61% compared to the previous year's 6.08 billion. Earnings were 174.27 million, a decrease of -70.59%.